Failure of TRPC6 inhibition to prevent COVID-19 deterioration: more questions than answers.
作者信息
Levy Elizabeth, Meyer Nuala J
机构信息
Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Division of Pulmonary, Allergy, and Critical Care Medicine, Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
出版信息
Thorax. 2023 Aug;78(8):741-742. doi: 10.1136/thorax-2023-220119. Epub 2023 Jun 7.
Abstract
摘要
相似文献
1
Failure of TRPC6 inhibition to prevent COVID-19 deterioration: more questions than answers.瞬时受体电位通道蛋白6（TRPC6）抑制未能预防新型冠状病毒肺炎（COVID-19）病情恶化：问题多于答案。
Thorax. 2023 Aug;78(8):741-742. doi: 10.1136/thorax-2023-220119. Epub 2023 Jun 7.
2
TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial.TRPC6 抑制剂（BI 764198）降低 COVID-19 所致 ARDS 的风险和严重程度：一项 II 期随机对照试验。
Thorax. 2023 Aug;78(8):816-824. doi: 10.1136/thorax-2022-219668. Epub 2023 Apr 6.
3
TRPC6 is altered in COVID-19 pneumonia.TRPC6 在 COVID-19 肺炎中发生改变。
Chem Biol Interact. 2022 Aug 1;362:109982. doi: 10.1016/j.cbi.2022.109982. Epub 2022 May 20.
4
Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.粉防己碱通过阻断 RhoA/ROCK1 信号通路抑制瞬时受体电位阳离子通道蛋白 6 过表达诱导的足细胞损伤。
Drug Des Devel Ther. 2020 Jan 28;14:361-370. doi: 10.2147/DDDT.S234262. eCollection 2020.
5
Pharmacological and genetic inhibition of TRPC6-induced gene transcription.TRPC6诱导的基因转录的药理学和遗传学抑制
Eur J Pharmacol. 2020 Nov 5;886:173357. doi: 10.1016/j.ejphar.2020.173357. Epub 2020 Aug 3.
6
Transient receptor potential channel 6 knockdown prevents apoptosis of renal tubular epithelial cells upon oxidative stress via autophagy activation.瞬时受体电位通道 6 敲低通过自噬激活防止氧化应激诱导的肾小管上皮细胞凋亡。
Cell Death Dis. 2018 Oct 3;9(10):1015. doi: 10.1038/s41419-018-1052-5.
7
Potential Drug Candidates to Treat TRPC6 Channel Deficiencies in the Pathophysiology of Alzheimer's Disease and Brain Ischemia.治疗阿尔茨海默病和脑缺血病理生理中 TRPC6 通道缺陷的潜在药物候选物。
Cells. 2020 Oct 24;9(11):2351. doi: 10.3390/cells9112351.
8
Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity.磷酸二酯酶 5 抑制通过蛋白激酶 G 介导的 TRPC6 活性下调改善血管紧张素 II 诱导的足细胞运动障碍。
Am J Physiol Renal Physiol. 2014 Jun 15;306(12):F1442-50. doi: 10.1152/ajprenal.00212.2013. Epub 2014 Apr 16.
9
The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.钙依赖性蛋白酶钙蛋白酶-1 将 TRPC6 活性与足细胞损伤联系起来。
J Am Soc Nephrol. 2018 Aug;29(8):2099-2109. doi: 10.1681/ASN.2016111248. Epub 2018 Jun 28.
10
Elucidation of a TRPC6-TRPC5 channel cascade that restricts endothelial cell movement.对限制内皮细胞移动的TRPC6-TRPC5通道级联反应的阐释。
Mol Biol Cell. 2008 Aug;19(8):3203-11. doi: 10.1091/mbc.e07-08-0765. Epub 2008 May 21.
本文引用的文献
1
TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial.TRPC6 抑制剂（BI 764198）降低 COVID-19 所致 ARDS 的风险和严重程度：一项 II 期随机对照试验。
Thorax. 2023 Aug;78(8):816-824. doi: 10.1136/thorax-2022-219668. Epub 2023 Apr 6.
2
Transient Receptor Potential (TRP) Channels in Airway Toxicity and Disease: An Update.瞬时受体电位（TRP）通道在气道毒性和疾病中的作用：最新进展。
Cells. 2022 Sep 17;11(18):2907. doi: 10.3390/cells11182907.
3
Opportunities for improved clinical trial designs in acute respiratory distress syndrome.急性呼吸窘迫综合征临床试验设计的改进机会。
Lancet Respir Med. 2022 Sep;10(9):916-924. doi: 10.1016/S2213-2600(22)00294-6.
4
Acute respiratory distress syndrome.急性呼吸窘迫综合征。
Lancet. 2021 Aug 14;398(10300):622-637. doi: 10.1016/S0140-6736(21)00439-6. Epub 2021 Jul 1.
5
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.在严重 COVID-19 患者中使用伊马替尼：一项随机、双盲、安慰剂对照的临床试验。
Lancet Respir Med. 2021 Sep;9(9):957-968. doi: 10.1016/S2213-2600(21)00237-X. Epub 2021 Jun 18.
6
Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research.精准医学在急性呼吸窘迫综合征中的应用：研讨会报告及未来研究建议。
Eur Respir Rev. 2021 Feb 2;30(159). doi: 10.1183/16000617.0317-2020. Print 2021 Mar 31.
7
Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.静脉注射干扰素 β-1a 对中重度急性呼吸窘迫综合征患者死亡和机械通气天数的影响：一项随机临床试验。
JAMA. 2020 Feb 25;323(8):725-733. doi: 10.1001/jama.2019.22525.
8
Pharmacological agents for adults with acute respiratory distress syndrome.用于成人急性呼吸窘迫综合征的药物制剂。
Cochrane Database Syst Rev. 2019 Jul 23;7(7):CD004477. doi: 10.1002/14651858.CD004477.pub3.
9
Modulators of Transient Receptor Potential (TRP) Channels as Therapeutic Options in Lung Disease.瞬时受体电位（TRP）通道调节剂作为肺部疾病的治疗选择
Pharmaceuticals (Basel). 2019 Feb 1;12(1):23. doi: 10.3390/ph12010023.
10
A (+)-Larixol Congener with High Affinity and Subtype Selectivity toward TRPC6.一种对 TRPC6 具有高亲和力和亚型选择性的 (+)-拉瑞辛同系物。
ChemMedChem. 2018 May 23;13(10):1028-1035. doi: 10.1002/cmdc.201800021. Epub 2018 Apr 26.
Zotero 插件